These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 16205603)

  • 21. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral hypercalcemia in patients with colorectal carcinoma: report of two cases and review of the literature.
    Lortholary AH; Cadeau SD; Bertrand GM; Guerin-Meyer VI; Gamelin EC; Audran MJ
    Cancer; 1999 Dec; 86(11):2217-21. PubMed ID: 10590360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vulvar carcinoma with hypercalcemia.
    Niebyl JR; Genadry R; Friedrich EG; Wilkinson EF; Woodruff JD
    Obstet Gynecol; 1975 Mar; 45(3):343-8. PubMed ID: 1113957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytokines in bone diseases. Cytokines and malignancy-associated hypercalcemia].
    Okazaki R
    Clin Calcium; 2010 Oct; 20(10):1497-502. PubMed ID: 20890031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
    Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudohyperparathyroidism in a mare associated with squamous cell carcinoma of the vulva.
    Karcher LF; Le Net JL; Turner BF; Reimers TJ; Tennant BC
    Cornell Vet; 1990 Apr; 80(2):153-62. PubMed ID: 2318041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of humoral hypercalcemia of malignancy among hypercalcemic patients with cancer.
    Szymanski JJ; Otrock ZK; Patel KK; Scott MG
    Clin Chim Acta; 2016 Jan; 453():190-3. PubMed ID: 26706788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.
    Stewart AF
    J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
    Sato K; Onuma E; Yocum RC; Ogata E
    Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic hypercalcemia with adenosquamous carcinoma of the colon.
    Fujita T; Fukuda K; Nishi H; Takao T; Ohmura Y; Mano M; Komatsubara S
    Int J Clin Oncol; 2005 Apr; 10(2):144-7. PubMed ID: 15864702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of parathyroid hormone-related peptide producing gallbladder carcinoma presenting humoral hypercalcemia of malignancy].
    Imoto Y; Muguruma N; Kimura T; Kaji M; Miyamoto H; Okamura S; Ito S; Nakasono M; Hirokawa M; Sano T
    Nihon Shokakibyo Gakkai Zasshi; 2007 Mar; 104(3):401-6. PubMed ID: 17337878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypercalcemia in malignancies of the female genital tract].
    Piura B
    Harefuah; 2008 Mar; 147(3):229-34, 277. PubMed ID: 18488865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercalcemia induced by parathyroid hormone-related peptide after treatment of carcinoma.
    Gover A; Kumar PD; Brown LA; Ravakhah K
    South Med J; 2002 Feb; 95(2):258-60. PubMed ID: 11846257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercalcemia due to parathyroid hormone-related protein produced by primary ovarian clear cell adenocarcinoma: case report.
    Tsunematsu R; Saito T; Iguchi H; Fukuda T; Tsukamoto N
    Gynecol Oncol; 2000 Feb; 76(2):218-22. PubMed ID: 10637074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
    Wysolmerski JJ; Broadus AE
    Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid hormone-related protein in an esophageal squamous cell carcinoma with tumor-induced hypercalcemia.
    Jaïs P; Bouizar Z; Binn M; Vissuzaine C; Hayem G; Mignon M; Lewin MJ
    Am J Gastroenterol; 1997 Feb; 92(2):343-6. PubMed ID: 9040221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of parathyroid hormone-related protein mRNA in tumors obtained from patients with humoral hypercalcemia of malignancy.
    Honda S; Yamaguchi K; Suzuki M; Sato Y; Adachi I; Kimura S; Abe K
    Jpn J Cancer Res; 1988 Jun; 79(6):677-81. PubMed ID: 3137193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extragonadal nonseminomatous germ cell tumour with hypercalcemia, masquerading as renal cell carcinoma: a case report.
    MacDiarmid SA; Norman RW
    Can J Surg; 1995 Feb; 38(1):80-2. PubMed ID: 7882217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
    Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
    Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute hypercalcaemic crisis in the course of PTH-rP producing squamous cell carcinoma of the skin--a case report].
    Bielec A; Czarkowski M; Gierej B; Bartoszewicz Z
    Pol Merkur Lekarski; 2005 Dec; 19(114):788-90. PubMed ID: 16521424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.